ClearView Life Insurance Australia — What You Need to Know
Updated: Aug 1
Written by Christopher Hall, AdvDipFP | Authorised Representative, AFSL 526688 | June 2026 · Updated August 2026
ClearView is an Australian-owned, ASX-listed specialist life insurer (ASX: CVW) that distributes advised life-risk products — its ClearChoice range — through financial advisers. It is a boutique-scale insurer, holding around 3.9% of the retail advised life market and A$412.9 million of in-force premium at 30 June 2025 (ClearView Wealth, 2025). In February 2026, ClearView agreed to be acquired by Zurich, with completion anticipated in the third quarter of 2026, subject to regulatory, shareholder and court approval (Zurich Australia, 2026).
Australia's life insurance industry is regulated by APRA under the Life Insurance Act 1995, with all major insurers required to submit quarterly financial data and maintain capital reserves against policyholder obligations. The consolidation of Australia's insurance market over recent years — where exiting or acquired insurers have transferred policyholder contracts to larger carriers — demonstrates that this regulatory framework protects policyholders regardless of individual insurer changes.
ClearView is on the Arrow Equities approved product list. Christopher Hall, AdvDipFP, Authorised Representative, AFSL 526688, reviews all ten insurers on the panel against each client's individual circumstances — age, occupation, medical background, cover levels, and financial position — before any recommendation is made.
Who is ClearView?
ClearView traces its origins to NRMA Life, founded in 1976, and was relaunched under the ClearView brand in 2010. It is headquartered in Sydney and listed on the ASX, with private-equity group Crescent Capital Partners its largest shareholder at roughly 53%. Its flagship product suite is ClearView ClearChoice, distributed through financial advisers. At boutique scale — around 3.9% of the retail advised life market and A$412.9 million of in-force premium at 30 June 2025 (ClearView Wealth, 2025) — ClearView sits well below the major insurers on size, while remaining a long-standing participant in the advised life market.
The defining development for 2026 is ownership. On 24 February 2026, ClearView entered a scheme implementation deed under which Zurich Financial Services Australia agreed to acquire 100% of the company, valuing its equity at approximately A$415 million (65 cents cash per share). ClearView's board unanimously recommended the scheme, and Crescent Capital indicated its intention to vote in favour. The ACCC granted clearance in mid-May 2026, with APRA approval, a shareholder vote (scheme meeting expected around mid-August 2026), and NSW Supreme Court approval still to follow; completion is anticipated in the third quarter of 2026 (Zurich Australia, 2026; Money Management, 2026). The insurer subsidiary is Clearview Life Assurance Limited, and the ClearChoice product is expected to continue under Zurich's custodianship. Arrow Equities has covered the transaction in more detail in what the Zurich acquisition means for ClearView policyholders.
Who issues a ClearView policy, and under what licence?
ClearView ClearChoice policies are issued by ClearView Life Assurance Limited (ABN 12 000 021 581, AFSL 227682), a life company registered under the Life Insurance Act 1995, prudentially regulated by APRA and holding its own Australian Financial Services Licence issued by ASIC. Where the same cover is held inside superannuation as ClearChoice Super, a separate trustee sits in the chain — HTFS Nominees Pty Limited (ABN 78 000 880 553, AFSL 232500) — and the insurance is provided to that trustee rather than directly to the member (ClearView Life Assurance Limited, ClearChoice Product Disclosure Statement).
For a policyholder, that structure has two practical consequences, and both are sharpened by the pending acquisition. First, the contract and the statutory fund holding the assets behind a claim sit with the Australian-regulated life company, and a change of ownership does not of itself change either: if the transaction completes, any transfer of the life insurance business would run through the court-approved scheme process in the Life Insurance Act under APRA supervision, carrying existing policy terms across rather than rewriting them. Second, where cover is held through ClearChoice Super, a benefit is paid to the trustee and then released to the member under the superannuation rules — which is why the conditions of release, not just the policy definitions, determine when the money actually reaches the member.
What personal insurance products does ClearView offer?
ClearView offers all four standard personal-risk lines through the ClearChoice suite: life (term) cover, total and permanent disability cover (TPD), income protection, and trauma (critical illness) cover, alongside child and accident covers and business-expense cover. Across the four main product lines there are no notable gaps relative to the rest of the advised market.
One structural feature is worth noting. ClearView's income protection sits within the industry-wide redesign of individual disability income insurance (IDII) that APRA introduced — agreed-value cover was discontinued from March 2020, and income-at-time-of-claim assessment and five-year policy contract terms applied from 1 October 2021 (APRA, 2021). These changes were driven by APRA and applied across the industry; Zurich was among the first insurers to move to the redesigned income protection structure, with ClearView and other insurers adopting similar designs. ClearView's ClearChoice income protection is structured to allow the full premium to be funded through superannuation where a client chooses that arrangement. The precise structure of any policy should be confirmed against the current ClearChoice Product Disclosure Statement at the point of advice.
Christopher Hall's experience with ClearView clients
Across Christopher Hall's 500+ life insurance policy reviews, ClearView products appear regularly as a candidate for consideration depending on the client's circumstances.
The pattern Christopher Hall returns to most often with ClearView is administration. In his experience, ClearView's application and policy-amendment forms are among the most time-consuming in the market to complete and sign correctly. Changes that should be routine can also be heavy going: even reducing a sum insured can be more involved than expected, and in Christopher Hall's experience an ownership change can take three to six months to process — a long turnaround for what should be a standardised administrative task. These observations relate to back-office processing rather than the cover itself, and they are the kind of practical friction a client rarely sees in a quote but encounters once a policy is in force and needs to be changed.
Recent changes at ClearView
The most significant change at ClearView is the pending Zurich acquisition described above — by some distance the most material development affecting the insurer in the last 12 to 18 months, and one Arrow Equities continues to track through its Australian life insurance industry news coverage.
In Christopher Hall's experience, since the sale was announced some back-office processes — repricing, new quotes, cover amendments, and adjustments to in-progress applications — have taken longer to turn around, while front-of-house service has held up. He reads this as consistent with a business moving through an ownership transition rather than as a statement about the company's conduct, and it is an observation from his own review practice rather than a published fact.
On claims, APRA's most recent life insurance claims and disputes statistics — released 15 April 2025, covering the 12 months to 31 December 2024 — record ClearView as accepting 91.0% of income protection claims, against an industry average of 94.4%, with an average income protection claim processing time of 2.3 months. These were the lowest acceptance rate and the longest average processing time of the insurers included in that dataset (APRA, 2025). The figures cover advised income protection claims for that 12-month period only.
For existing ClearView policyholders, the most relevant question raised by the takeover is whether ClearChoice remains an on-sale product or eventually becomes a closed, legacy book. Products that remain open to new business tend to keep being invested in and repriced competitively; products closed to new business tend, over time, to attract larger premium increases relative to current products with similar features, because the pool no longer takes new entrants (riskinfo, 2024). This is an industry-wide pricing pattern — the same loyalty tax dynamic that affects long-standing policies across insurers — rather than anything specific to ClearView. If Zurich retains the brand and the ClearChoice product, existing clients may see limited near-term change; if the product is eventually closed, history suggests a higher likelihood of more significant premium increases over time.
Is ClearView the right insurer for a client's situation?
Whether ClearView suits a particular client depends on their individual circumstances — age, occupation, medical background, the cover structure required, financial position, and any existing cover already in place. For an existing ClearView or ClearChoice policyholder, the ownership change is itself a reason a review is worth considering: it creates uncertainty about whether the product stays current or drifts toward legacy status, and that uncertainty is precisely what a review is designed to assess.
What actually determines whether ClearView suits a client right now
In practice the decision turns on a small number of concrete variables rather than a general view of the insurer.
Existing policy, or new cover being placed today. For an existing ClearChoice policyholder the live question is whether the product stays open to new business once the acquisition completes, because that is what drives the repricing pattern described above. For someone placing new cover now, the question is different: whether to decide before or after completion, which is anticipated in the third quarter of 2026 and still subject to APRA approval, a shareholder vote and NSW Supreme Court approval.
Whether the cover is held inside superannuation. ClearChoice Super introduces a separate trustee into the chain, which changes who a benefit is paid to and when it can be released to the member.
How often the policy is likely to be changed. The administrative turnaround described above — particularly on ownership changes and cover amendments — matters far more to a client who expects to restructure cover, move a policy into or out of a self-managed super fund, or vary sums insured, than to one who intends to set the policy and leave it in place.
The claims and processing figures, read for the cohort they cover. The APRA data cited above covers advised income protection claims for a single 12-month period. It is one input among several and describes that cohort and period, not the likely handling of any individual claim.
The client's own circumstances. Age, occupation, medical history, the cover types and amounts required, existing cover already in place, and how premiums will be funded remain the variables that decide the outcome — and they are assessed at the time of review, against the whole panel rather than against ClearView alone.
Life insurance products sold through online comparison sites, TV advertising, or weekly premium structures are often white-labelled versions of products offered by the same major insurers. In Christopher Hall's experience across 500+ policy reviews, the product terms, definitions, and flexibility available through a licensed adviser who holds the insurer's products on an approved product list can differ significantly from those accessible through a direct online quote — sometimes from the same insurer. Policyholders weighing up ClearView, or any insurer, may wish to compare it against the broader market with a specialist life insurance advice practice. A professional life insurance premium review across the market is the natural starting point.
Which other insurers does Arrow Equities compare ClearView against?
When an existing ClearView policy is being reviewed, or when ClearView comes up in a new client comparison, Arrow Equities typically compares it against the other insurers on the approved product list:
Frequently Asked Questions
Is ClearView life insurance any good?
ClearView is an APRA-regulated life insurer — Clearview Life Assurance Limited submits quarterly financial data to APRA and maintains capital reserves against policyholder obligations, as all Australian life insurers must. Whether ClearView is the right fit for a particular person depends on their age, occupation, health, and cover needs, which is what a professional comparison across the market assesses.
What does the Zurich acquisition mean for an existing ClearView policyholder?
Zurich agreed to acquire ClearView in February 2026, with completion anticipated in the third quarter of 2026 subject to regulatory, shareholder and court approval (Zurich Australia, 2026). The ClearChoice product is expected to continue under Zurich's custodianship. The practical question for existing policyholders is whether their product remains on-sale or eventually becomes a closed legacy book — which can affect future premium movements — and a review is one way to assess that position.
Does ClearView offer income protection insurance?
Yes. ClearView offers the full suite of personal risk cover through its ClearChoice range — life, TPD, income protection, and trauma (critical illness) — along with child, accident, and business-expense covers. Policies can be structured inside or outside superannuation.
Can ClearView income protection be funded through superannuation?
ClearView's ClearChoice income protection is structured to allow the full premium to be funded through superannuation where a client chooses that arrangement. The exact structure and any conditions should be confirmed against the current ClearChoice Product Disclosure Statement at the point of advice.
What happens to a ClearView policy if it becomes a legacy product?
Products closed to new business tend, over time, to attract larger premium increases relative to current products with similar features, because the pool no longer takes new entrants (riskinfo, 2024). This is an industry-wide pricing pattern rather than anything specific to ClearView. If the ClearChoice brand and product are retained, near-term change may be limited; if the product is eventually closed, history suggests a higher likelihood of more significant premium increases over time.
What should I check if I already have a ClearView or ClearChoice policy?
Existing policyholders may wish to confirm whether their product remains on-sale, review their current premium against comparable market rates, and check that the cover structure still matches their circumstances — particularly given the ownership change. A professional review can compare the existing policy against the full panel of insurers and confirm whether the cover and pricing remain appropriate.
Check if you're eligible for an Arrow Equities insurance review
A review compares an existing or quoted ClearView or ClearChoice policy against the full panel of insurers, considers what the Zurich acquisition may mean for the product, and identifies any loyalty tax gap on long-standing cover.
About the AuthorChristopher Hall, AdvDipFP, is the principal financial adviser at Arrow Equities and an Authorised Representative under AFSL 526688. He has completed more than 500 life insurance policy reviews for Australian families, with a specialisation in life risk insurance.
Bibliography
# | Source | Type | Date |
1 | ClearView Wealth Limited 2025, FY25 financial results, ASX market release, ClearView Wealth Limited, August 2025, viewed June 2026, <https://www.listcorp.com/asx/cvw/clearview-wealth-limited> | Company disclosure | August 2025 |
2 | Zurich Australia 2026, Zurich Australia enters into agreement to acquire ClearView, media release, Zurich Financial Services Australia, 24 February 2026, viewed June 2026, <https://www.zurich.com.au/latest-news/media-releases/2026/2026-02-24> | Company disclosure | February 2026 |
3 | Money Management 2026, 'ACCC waves through Zurich's $415m ClearView takeover', Money Management, 15 May 2026, viewed June 2026, <https://www.moneymanagement.com.au/accc-waves-through-zurichs-415-million-clearview-takeover/> | Tier 2 — editorial | May 2026 |
4 | Australian Prudential Regulation Authority 2021, Individual disability income insurance sustainability measures, APRA, Sydney, viewed June 2026, <https://www.apra.gov.au> | Tier 1 — regulatory | 2021 |
5 | Australian Prudential Regulation Authority 2025, Life insurance claims and disputes statistics (year ending 31 December 2024), APRA, Sydney, released 15 April 2025, viewed June 2026, <https://www.apra.gov.au/life-insurance-claims-and-disputes-statistics> | Tier 1 — regulatory | April 2025 |
6 | riskinfo 2024, 'Loyal life insurance customers paying higher premiums', riskinfo, 17 September 2024, viewed June 2026, <https://riskinfo.com.au/news/2024/09/17/loyal-life-insurance-customers-paying-higher-premiums/> | Tier 2 — editorial | September 2024 |
Educational Disclaimer: This content is for educational purposes only and does not constitute financial advice. Past performance is no guarantee of future results.
The information, opinions and other materials appearing on the Web Site are of a general nature only and shall not be construed as advice. Arrow Equities is a trading name of Rose Bay Equities Pty Ltd, AFSL 526688, ABN 87 645 284 680. This general information is educational only and not financial advice, recommendation, forecast or solicitation. Arrow Equities accepts no responsibility for the accuracy or completeness of the information, opinions or other materials provided on or accessible through the Web Site. The Web Site has not been prepared with reference to your individual financial or personal circumstances. You should not rely on any advice in this Web Site without first seeking appropriate professional, financial and legal advice. Further, where Arrow Equities makes third party material available or accessible through the Web Site you acknowledge that Arrow Equities is a distributor and not a publisher of that content and that its editorial control is limited to the selection of those materials to make available. We accept no liability for any loss or damages arising from use.
Comments